Researchers from the University of Winnipeg (UWinnipeg) and the University of Saskatchewan (USask) have taken on an ambitious challenge: build the ground for the next revolution in global farming and food production. With support from George Weston Limited and Mitacs, the team is filling a gap within the digital agriculture field by building a robotic system to create an open dataset of Canadian prairie crop plants and weeds.
With the onset of the COVID-19 crisis, CAMufacturing Solutions Inc. knew they needed to bring their expertise in additive manufacturing, or 3D printing, to support the rising demand for quick production of personnel protective equipment (PPE) for the health care community.
Gum disease is a condition that shows up in 85 percent of cats and dogs before the age of four. Without proper treatment, the illness is painful and can lead to other health issues such as heart or kidney disease.
To improve the health of pets and prevent the issue, Quebec entrepreneur Andrée-Ann Adam has been working on a first-of-its-kind, all-natural dental gel.
A global pandemic didn’t stop Toronto entrepreneur Raghavender Sahdev from innovating. On the contrary, he spent the time propelling his start-up, NuPort Robotics, Canada’s first autonomous trucking company, which will help advance Canada’s trucking industry far into the future by using eco-friendly, self-driving electric trucks for short-haul shuttle runs between distribution centres, warehouses, and ports.
During her undergrad studies at the University of Calgary, Taylor Markham found her passion for mathematics and how cryptography demonstrates the use of mathematical concepts in everyday life applications.
In 2019, she was the first Faculty of Science student at the University of Calgary to apply for the Mitacs Globalink Research Award. Through this program, Markham spent her final summer as an undergrad student conducting research at the University of Hawai’i at Mānoa, where she was supervised by Annie Carter in the Department of Mathematics and Statistics.
When the second wave of the Spanish flu hit Canada over 100 years ago, the effect was even more devastating than that of its first wave. In fact, 90 percent of the deaths happened in the fall of 1918, during the pandemic’s second peak.
When Gurudeeban Selvaraj and Satyavani Kaliamurthi came to Canada in 2019, they had no idea they would be creating both a preventative vaccine and a curing drug to address the millennium’s biggest pandemic.
As of May 27, 2020, there have been 2,925,466 infected COVID-19 patients reported worldwide, with a total of 355,727 deaths. The rapid progression of the COVID-19 pandemic has raised concerns regarding the short supply of medical equipment needed to control the rate of transmission and mortality. In most developing countries, transporting vaccines can be difficult without the proper storage technologies, since vaccines and equipment can spoil in high temperatures.